DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Osanetant
Osanetant
Nitrate Prodrugs Able to Release Nitric Oxide in a Controlled and Selective
Tachykinins and Airway Microvascular Leakage Induced by Hcl Intra-Oesophageal Instillation
Selective Blockade of NK2 Or NK3 Receptors Produces Anxiolytic- and Antidepressant-Like Effects in Gerbils ⁎ N
G Protein-Coupled Receptors
G Protein‐Coupled Receptors
Neurokinin Receptor NK Receptor
Stembook 2018.Pdf
Acer Therapeutics Inc. Form 8-K Current Event Report Filed 2021-06
(12) Patent Application Publication (10) Pub. No.: US 2008/0045610 A1 Michallow (43) Pub
(12) Patent Application Publication (10) Pub. No.: US 2006/0069086 A1 Michallow (43) Pub
Title Scaffold Hopping of Fused Piperidine-Type NK3 Receptor
Non-Confidential Pipeline Update
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Sanofi-Aventis Needs Successes, Not Failures
Biological Markers for Anxiety Disorders, OCD and PTSD: a Consensus Statement
Innovative Drugs to Treat Depression: Did Animal Models Fail to Be Predictive Or Did Clinical Trials Fail to Detect Effects?
Pharmaabkommen A1 E
Localization and Function of Nk3 Subtype Tachykinin
Top View
Customs Tariff - Schedule Xxi - 1
REED Vulva LA Tak Due 1-15-16 Vulvar Talk LA January 2016.Pptx 1
(12) Patent Application Publication (10) Pub. No.: US 2010/0234360 A1 Michallow (43) Pub
Current and Future Applications of Gnrh, Kisspeptin and Neurokinin B Analogues
Characterization of Species-Related Differences in the Pharmacology Of
Neuropeptide Receptors in Pain Circuitries: Useful Targets for CNS Imaging with Non-Peptide Ligands Suitable for PET?
Tachykinin Receptors (Version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database
G Proteinactivation
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Non-Confidential Corporate Presentation
In Vitro and in Vivo Characterization of the Non-Peptide NK3 Receptor
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
G Protein-Coupled Receptors
Title Structure-Activity Relationships for Development of Neurokinin-3
Biological Markers for Anxiety Disorders, OCD and PTSD: a Consensus Statement
Acer Therapeutics Inc. Form 8-K Current Event Report Filed 2020-01